Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
80
datasets available to search
ShareScore release 0.9.0
Dataset results
80 results for “Respiratory symptoms”
Coswara: A respiratory sounds and symptoms dataset for remote screening of SARS-CoV-2 infection
<p>Coswara is a dataset containing diverse set of respiratory sounds and rich meta-data from COVID-19 positive and Non-COVID subjects.</p>
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
ClinicalTrials.gov study NCT02790034. IPD Sharing: Not stated. Countries: 5. Publications: 27.
FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates
ClinicalTrials.gov study NCT01328873. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
ClinicalTrials.gov study NCT02491684. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
ClinicalTrials.gov study NCT01272635. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
ClinicalTrials.gov study NCT02024204. IPD Sharing: Not stated. Countries: 1. Publications: 3.
The impact of a heat and moisture exchange mask on respiratory symptoms and airway response to exercise in asthma
Open the record for dataset details and reuse information.
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
<p><b>Background:</b> The burden of the COVID-19 pandemic in Peru has led to people seeking alternative treatments as preventives and treatment options such as medicinal plants. This study aimed to assess factors associated with the use of medicinal plants as preventive or treatment of respiratory symptom related to COVID-19 during the pandemic in Cusco, Peru.<b> </b></p> <p><b>Method: </b>A web-based cross-sectional study was conducted on general public (20- to 70-year-old) from August 31 to September 20, 2020. Data were collected using a structured questionnaire via Google Forms, it consisted of an 11-item questionnaire that was developed and validated by expert judgment using Aiken's V (Aiken's V > 0.9). Both descriptive statistics and bivariate followed by multivariable logistic regression analyses were conducted to assess factors associated with the use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic. Prevalence ratios (PR) with 95% Confidence Interval (CI), and a P-value of 0.05 was used to determine statistical significance.</p> <p><b>Results: </b>A total of 1,747 respondents participated in the study, 80.2% reported that they used medicinal plants as preventives, while 71% reported that they used them to treat respiratory symptoms. At least, 24% of respondents used medicinal plants when presenting with two or more respiratory symptoms, while at least 11% used plants for malaise. For treatment or prevention, the multivariate analysis showed that most respondents used eucalyptus (p < 0.001 for both), ginger (p < 0.022 for both), spiked pepper (p < 0.003 for both), garlic (p = 0.023 for prevention), and chamomile (p = 0.011 for treatment). The respondents with COVID-19 (p < 0.001), at older ages (p = 0.046), and with a family member or friend who had COVID-19 (p < 0.001) used more plants for prevention. However, the respondents with technical or higher education used less plants for treatment (p < 0.001).</p> <p><b>Conclusion: </b>There was a significant use of medicinal plants for both prevention and treatment, which was associated with several population characteristics and whether respondents had COVID-19.</p>
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
ClinicalTrials.gov study NCT00599430. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effect of Yoga on Respiratory Functions, Symptom Control and Life Quality of Asthma Patients
ClinicalTrials.gov study NCT04107415. IPD Sharing: NO. Countries: 1. Publications: 2.
Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms
ClinicalTrials.gov study NCT01909128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Work-related Respiratory Symptoms in Champagne Vineyard Workers
ClinicalTrials.gov study NCT02883920. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms
ClinicalTrials.gov study NCT02294279. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:
ClinicalTrials.gov study NCT04695704. IPD Sharing: NO. Countries: 1. Publications: 1.
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
ClinicalTrials.gov study NCT05986318. IPD Sharing: NO. Countries: 1. Publications: 11.
Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms
ClinicalTrials.gov study NCT05794815. IPD Sharing: NO. Countries: 1. Publications: 2.
Assessment of Respiratory Symptoms After Corticosteroid Treatment Period Using Impedance Pneumography
ClinicalTrials.gov study NCT02164968. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms
ClinicalTrials.gov study NCT04420312. IPD Sharing: UNDECIDED. Countries: 1. Publications: 26.
Electroacupuncture Modulates SPMs Metabolism and Respiratory Symptoms in Patients With Sepsis Complicating ARDS
ClinicalTrials.gov study NCT06006325. IPD Sharing: NO. Countries: 1. Publications: 4.
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
ClinicalTrials.gov study NCT04368156. IPD Sharing: UNDECIDED. Countries: 1. Publications: 35.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.